Gene mutation of transforming growth factor β1 type II receptor in hepatocellular carcinoma

International Journal of Cancer

Volumn 81, Issue 6, 1999, Pages 851-853

  Furuta, Keiko ^a   Misao, Sachiko ^a   Takahashi, Kiyoshi ^a   Tagaya, Tsuneaki ^a   Fukuzawa, Yoshitaka ^a   Ishikawa, Tetsuya ^a   Yoshioka, Kentaro ^b   Kakumu, Shinichi ^a  

^a AICHI MEDICAL UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HEPATITIS C ANTIBODY; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; GENE DELETION; GENE MUTATION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; DINUCLEOTIDE REPEATS; DNA REPLICATION; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; LIVER NEOPLASMS; MICROSATELLITE REPEATS; MOLECULAR SEQUENCE DATA; MUTATION; POLY A; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REPETITIVE SEQUENCES, NUCLEIC ACID;

EID: 0032968104     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990611)81:6<851::AID-IJC2>3.0.CO;2-D     Document Type: Article

References (20)

1. AKIYAMA, Y., IWANAGA, R., SAITOH, K., SHIBA, K., USHIO, K., IKEDA, E., IWANA, T., NIMIZU, T. and YUASA Y., Transforming growth factor β type II receptor gene mutations in adenomas from hereditary nonpolyposis colorectal cancer. Gastroenterology, 112, 33-39 (1997).
2. BEDOSSA, P., PELTIER, E., TERRIS, B., FRANCO, D. and POYNARD, T., Transforming growth factor-beta 1 (TGF-β1) and TGF-β1 receptors in normal, cirrhotic, and neoplastic human livers. Hepatology, 21, 760-766 (1995).
3. DE SOUZA, A.T., HANKINS, G.R., WASHINTON, M.K., FINE, R.L., ORTON, T.C. and JIRTLE, J.L., Frequent loss of heterozygosity on 6q at the mannose-6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors. Oncogene, 10, 1725-1729 (1995a).
4. DE SOUZA, A.T., HANKINS, G.R., WASHINGTON, M.K., ORTON, T.C. and JIRTLE, J.L., M6P/IGF24 gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nature (Genet.), 11, 447-449 (1995b).
5. GOELZ, S.E., HAMILTON, S.R. and VOGELSTEIN, B., Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem. biophys. Res. Comm., 130, 118-126 (1985).
6. INAGAKI, M., MOUSTAKAS, A., LIN, H.Y., LODISH, H.F. and CARR, B.I., Growth inhibition by transforming growth factor β (TGF-β) type I is restored in TGF-β-resistant hepatoma cells after expression of TGF-β receptor type II cDNA. Proc. natl. Acad. Sci. (Wash.), 90, 5359-5363 (1993).
7. KIYOSAWA, K., SODEYAMA, T., TANAKA, E., GIBO, Y., YOSHIZAWA, K., NAKANO, Y., FURUTA, S., AKAHANE, Y., NISHIOKA, K., PURCELL, R.H. and ALTER, H.J., Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology, 12, 671-675 (1990).
8. LIN, H.Y., WANG, X.-F., NG-EATON, E., WEINBERG, R.A. and LODISH, H.F., Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell, 68, 775-785 (1992).
9. MARKOWITZ, S., QANG, J., MYEROFF, L., PARSONS, R., SUN, L., LUTTERBAUGH, J., FAN, R.S., ZBOROWSKA, E., KINZLER, K.W., VOGELSTEIN, B., BRATTAIN, M. and WILSON, J.K.V., Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science, 268, 1336-1338 (1995).
10. MELTZER, S.J., YIN, J., HUANG, Y., MCDANIEL, T.K., NEWKIRK, C., ISERI, O., VOGELSTEIN, B. and RESAU, J.H., Reduction to homozygosity involving p53 in esophageal cancers demonstrated by the polymerase chain reaction. Proc. nat. Acad. Sci. (Wash.), 88, 4976-4980 (1991).
11. PARK, K., KIN. S.-J., BANG, Y.-J., PARK, J.-G., KIM, N.K., ROBERTS, A.B. and SPORN, M.B., Genetic changes in the transforming growth factor (TGF-β) type II receptor in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc. nat. Acad. Sci. (Wash.), 91, 8772-8776 (1994).
12. PARSONS, R., MYEROFF, L.L., LIU, B., WILSON, J.K.V., MARKOWITZ, S.D., KINZLER, K.W. and VOGELSTEIN, B., Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer. Cancer Res., 55, 5548-5550 (1995).
13. SCHUTER, M.J. and WU, G.Y., Gene therapy for hepatocellular carcinoma: progress but many stones yet unturned! Gastroenterology, 112, 656-659 (1997).
14. SERRA, R. and MOSES, H.L., Tumor suppressor genes in the TGF-β signaling pathway? Nature (Med.), 2, 390-391 (1996).
15. SOUZA, R.F., and 20 others. Microsatellite instability in the insulin-like growth factor II receptor gene in human gastrointestinal tumors. Nature (Genet.), 14, 255-257 (1996).
16. SOUZA, R.F and 19 OTHERS, A transforming growth factor β1 receptor type II mutation in ulcerative colitis-associated neoplasms. Gastroenterology, 112, 40-45 (1997).
17. SUZUKI, H., HARPAZ, N., TARMIN, L., YIN, J., JIANG, H.-Y., BELL, J.D., HONTANOSAS, M., GROISMAN, G.M., ABRAHAM, J.M. and MELTZER, S.J., Microsatellite instability in ulcerative colitis-associated colorectal dysplasias and cancers. Cancer Res., 54, 4841-4844 (1994).
18. VINCENT, F., HAGIWARA, K., KE, Y., STONER, G.D., DEMETRICK, D.J. and BENNETT, W.P., Mutation analysis of the transforming growth factor ( type II receptor in sporadic human cancers of the pancreas, liver, and breast. Biochem. biophys. Res. Comm., 223, 561-564 (1996).
19. WEINER, A.J. and 14 others. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc. nat. Acad. Sci. (Wash.), 89, 3468-3472 (1992).
20. YAMADA, T., DE SOUZA, A.T., FINKELSTEIN, S. and JIRTLE, R.L., Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis. Proc. not. Acad. Sci. (Wash.), 94, 10351-10355 (1997).